Literature DB >> 17187268

Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1).

Eva Bakos1, László Homolya.   

Abstract

MRP1 (ABCC1) is a peculiar member of the ABC transporter superfamily for several aspects. This protein has an unusually broad substrate specificity and is capable of transporting not only a wide variety of neutral hydrophobic compounds, like the MDR1/P-glycoprotein, but also facilitating the extrusion of numerous glutathione, glucuronate, and sulfate conjugates. The transport mechanism of MRP1 is also complex; a composite substrate-binding site permits both cooperativity and competition between various substrates. This versatility and the ubiquitous tissue distribution make this transporter suitable for contributing to various physiological functions, including defense against xenobiotics and endogenous toxic metabolites, leukotriene-mediated inflammatory responses, as well as protection from the toxic effect of oxidative stress. In this paper, we give an overview of the considerable amount of knowledge which has accumulated since the discovery of MRP1 in 1992. We place special emphasis on the structural features essential for function, our recent understanding of the transport mechanism, and the numerous assignments of this transporter.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17187268     DOI: 10.1007/s00424-006-0160-8

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  187 in total

1.  Multidrug resistance related molecules in human and murine lung.

Authors:  G L Scheffer; A C L M Pijnenborg; E F Smit; M Müller; D S Postma; W Timens; P van der Valk; E G E de Vries; R J Scheper
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

2.  Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation.

Authors:  L D Cripe; V M Gelfanov; E A Smith; D R Spigel; C A Phillips; T G Gabig; S-H Jung; J Fyffe; A D Hartman; P Kneebone; D Mercola; G S Burgess; H S Boswell
Journal:  Leukemia       Date:  2002-05       Impact factor: 11.528

3.  The leucotriene C4 binding sites in multidrug resistance protein 1 (ABCC1) include the first membrane multiple spanning domain.

Authors:  Joel Karwatsky; Mara Leimanis; Jie Cai; Philippe Gros; Elias Georges
Journal:  Biochemistry       Date:  2005-01-11       Impact factor: 3.162

4.  Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas.

Authors:  M Fillpits; R W Suchomel; G Dekan; W Stiglbauer; K Haider; D Depisch; R Pirker
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Relationship between chemotherapy response of small cell lung cancer and P-glycoprotein or multidrug resistance-related protein expression.

Authors:  T-C Hsia; C-C Lin; J-J Wang; S-T Ho; A Kao
Journal:  Lung       Date:  2002       Impact factor: 2.584

6.  Temporal expression profiles of organic anion transport proteins in placenta and fetal liver of the rat.

Authors:  M V St-Pierre; T Stallmach; A Freimoser Grundschober; J-F Dufour; M A Serrano; J J G Marin; Y Sugiyama; P J Meier
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-09-02       Impact factor: 3.619

7.  Sequential emergence of MRP- and MDR1-gene over-expression as well as MDR1-gene translocation in homoharringtonine-selected K562 human leukemia cell lines.

Authors:  D C Zhou; S Ramond; F Viguie; A M Faussat; R Zittoun; J P Marie
Journal:  Int J Cancer       Date:  1996-01-26       Impact factor: 7.396

8.  Immunohistochemical detection of multidrug resistance protein in human lung cancer and normal lung.

Authors:  S R Wright; A H Boag; G Valdimarsson; D R Hipfner; B G Campling; S P Cole; R G Deeley
Journal:  Clin Cancer Res       Date:  1998-09       Impact factor: 12.531

9.  Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies.

Authors:  M J Flens; M A Izquierdo; G L Scheffer; J M Fritz; C J Meijer; R J Scheper; G J Zaman
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

10.  Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells.

Authors:  Z Holló; L Homolya; T Hegedüs; B Sarkadi
Journal:  FEBS Lett       Date:  1996-03-25       Impact factor: 4.124

View more
  47 in total

1.  Functional hot spots in human ATP-binding cassette transporter nucleotide binding domains.

Authors:  Libusha Kelly; Hisayo Fukushima; Rachel Karchin; Jason M Gow; Leslie W Chinn; Ursula Pieper; Mark R Segal; Deanna L Kroetz; Andrej Sali
Journal:  Protein Sci       Date:  2010-11       Impact factor: 6.725

2.  Mice lacking Mrp1 have reduced testicular steroid hormone levels and alterations in steroid biosynthetic enzymes.

Authors:  Jeffrey C Sivils; Iven Gonzalez; Lisa J Bain
Journal:  Gen Comp Endocrinol       Date:  2010-02-21       Impact factor: 2.822

3.  Functional diversification of sea urchin ABCC1 (MRP1) by alternative splicing.

Authors:  Tufan Gökirmak; Joseph P Campanale; Adam M Reitzel; Lauren E Shipp; Gary W Moy; Amro Hamdoun
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-06       Impact factor: 4.249

Review 4.  ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.

Authors:  Young Hee Choi; Ai-Ming Yu
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

5.  The Concise Guide to PHARMACOLOGY 2013/14: transporters.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

6.  Expression of ATP-Binding Cassette Transporters B1 and C1 after Severe Traumatic Brain Injury in Humans.

Authors:  F Anthony Willyerd; Philip E Empey; Ashley Philbrick; Milos D Ikonomovic; Ava M Puccio; Patrick M Kochanek; David O Okonkwo; Robert S B Clark
Journal:  J Neurotrauma       Date:  2015-06-17       Impact factor: 5.269

Review 7.  Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

Authors:  James J Beaudoin; Kim L R Brouwer; Melina M Malinen
Journal:  Pharmacol Ther       Date:  2020-04-02       Impact factor: 12.310

8.  Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines.

Authors:  Jun-Qiang Qian; Pei Sun; Zhan-Yu Pan; Zhi-Zhong Fang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

9.  Effluxing ABC transporters in human corneal epithelium.

Authors:  Kati-Sisko Vellonen; Eliisa Mannermaa; Helen Turner; Marika Häkli; J Mario Wolosin; Timo Tervo; Paavo Honkakoski; Arto Urtti
Journal:  J Pharm Sci       Date:  2010-02       Impact factor: 3.534

10.  Vandetanib (Zactima, ZD6474) antagonizes ABCC1- and ABCG2-mediated multidrug resistance by inhibition of their transport function.

Authors:  Li-sheng Zheng; Fang Wang; Yu-hong Li; Xu Zhang; Li-ming Chen; Yong-ju Liang; Chun-ling Dai; Yan-yan Yan; Li-yang Tao; Yan-jun Mi; An-kui Yang; Kenneth Kin Wah To; Li-wu Fu
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.